A Novel Nomogram Combined the Aggregate Index of Systemic Inflammation and PIRADS Score to Predict the Risk of Clinically Significant Prostate Cancer

<div>Decision curve for prediction of the risk of csPCa. Gray line: assume all patients will have csPCa; Black line: assume no patient will have csPCa; Red line: binary rule based on nomogram model.</div>

BioMed Research International

fig5

Figure 5

Figure 5: A Novel Nomogram Combined the Aggregate Index of Systemic Inflammation and PIRADS Score to Predict the Risk of Clinically Significant Prostate Cancer 

Figure 5 | A Novel Nomogram Combined the Aggregate Index of Systemic Inflammation and PIRADS Score to Predict the Risk of Clinically Significant Prostate Cancer 